Letter to the Editor: Serum Thrombospondin‐2 as biomarker in liver diseases, a look beyond NASH

This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi:10.1002/hep.32291

Comments (0)

No login
gif